Vaccine Immunity Against Pneumococcus in Children With Cochlear Implants
Our findings support the proactive administration of an additional pneumococcal vaccine dose at the time of planning cochlear implant surgery for children ≥2 years old. In addition, periodic monitoring of serotype-specific pneumococcal antibody levels (every 5 years) is recommended to determine the need for booster vaccinations.
Authors
- Hélène Cao Van (ORCID: https://orcid.org/0009-0003-8876-8937)
- Barbara Lemaître
- Klara Maria Posfay-Barbe (ORCID: https://orcid.org/0000-0001-9464-5704)
- Renato Gualtieri (ORCID: https://orcid.org/0000-0001-8164-7284)
- Géraldine Blanchard‐Rohner (ORCID: https://orcid.org/0000-0002-9974-2172)
- Audrey Hominal
Institutions
- University of Geneva (CH)
- Intravacc (Netherlands) (NL)
- University Hospital of Geneva (CH)
- Sacred Heart Hospital (US)
- Geneva College (US)
- University of Lausanne (CH)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1097/inf.0000000000004999
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.35